|
|
Title | Creator | Date |
| 1 |
 | Great Conversations: Dr. Barrett Katz | Meagan Seay; Elizabeth Fortin; Kathleen Digre | 2019-09 |
| 2 |
 | Treatment Response in Pediatric Patients With Pseudotumor Cerebri Syndrome | Eliel Tovia, MD; Shimon Reif, MD; Asaf Oren, MD; Alexis Mitelpunkt, MD; Aviva Fattal-Valevski, MD, MHA | 2017-12 |
| 3 |
 | Advances in Neuromyelitis Optica: Take Them to the Clinic | Marc H. Levin, MD, PhD | 2017-09 |
| 4 |
 | Annual Review of Systemic Disease | Lama, P; Frohman, L | |
| 5 |
 | Induced Pluripotent Stem Cells for Inherited Optic Neuropathies-Disease Modeling and Therapeutic Development | J. P. Harvey; P. E. Sladen; P. Yu-Wai-Man; M. E. Cheetham | 2022-03 |
| 6 |
 | Intracranial Hypertension in a Patient Preparing for Gestational Surrogacy With Leuprolide Acetate and Estrogen | Alexander, Joshua; Levi, Leah | |
| 7 |
 | Development of Dural Arteriovenous Fistulas After Cerebral Venous Sinus Thrombosis | Jonathan A. Micieli, MD, CM; Sheldon Derkatch, MD; Vitor M. Pereira, MD; Edward A. Margolin, MD | 2016-03 |
| 8 |
 | The Latest on Optical Coherence Tomography | Sergott, Robert C; Balcer, Laura J | |
| 9 |
 | High-Titer CRMP-5 Paraneoplastic Optic Neuropathy as the Only Clinical Manifestations in a Patient with Small Cell Lung Carcinoma | Margolin, E; Flint, A; Trobe, JD | |
| 10 |
 | Lyme disease. A neuro-ophthalmologic view. | MacDonald, A.B. | |
| 11 |
 | Patient Safety: Its History and Relevance to Neuro-Ophthalmology | Sophia M. Chung, MD; Philip L. Custer, MD, FACS | 2017-09 |
| 12 |
 | The spinocerebellar ataxias. | Paulson, Henry L | |
| 13 |
 | Idiopathic Sclerosing Orbital Inflammation: Presentation of an Unusual Case With Isolated Bilateral Optic Nerve Involvement | Galvez-Ruiz, Alberto; Chaudhry, Imtiaz; Al Katan, Hind | |
| 14 |
 | The Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple Sclerosis | Jodie M. Burton, MD, MSc, FRCPC; Mark S. Freedman, MSc, MD, FAAN, FANA, FRCPC | 2018-06 |
| 15 |
 | Teprotumumab in Thyroid-Associated Ophthalmopathy: Rationale for Therapeutic Insulin-Like Growth Factor-I Receptor Inhibition | Terry J. Smith | 2020-03 |
| 16 |
 | Leber's optic neuropathy and Charcot-Marie-Tooth disease. Report of a case. | McCluskey, D.J.; O'Connor, P.S.; Sheehy, J.T. | |
| 17 |
 | Extraocular Muscle Findings in Myasthenia Gravis Associated Treatment-Resistant Ophthalmoplegia | Robyn M. Rautenbach, MSc; Komala Pillay, MBChB; Anthony D. N. Murray, MBChB; Jeannine M. Heckmann, PhD | 2017-12 |
| 18 |
 | Acute Care and Treatment of Migraine | Spingos Konstantinos, MD, PgD; Michail Vikelis, MD, MSc, PhD; Alan Rapoport, MD | 2020-12 |
| 19 |
 | Literature Commentary | M. Tariq Bhatti; Mark L. Moster | 2020-03 |
| 20 |
| Literature Commentary: Double Feature - Take Two! | Mark L. Moster; MD; M. Tariq Bhatti; MD | 2020-03 |
| 21 |
 | The Treatment of Neuromyelitis Optica | Kowarik, Markus C; Soltys, John; Bennett, Jeffrey L | |
| 22 |
 | Emerging Gene Therapy Technologies for Retinal Ganglion Cell Neuroprotection | David K. Camacho; Cammille C. Go; Brahim Chaqour; Kenneth S. Shindler; Ahmara G. Ross | 2023-09 |
| 23 |
 | Optic Pathway Gliomas | Avery, Robert A; Fisher, Michael J; Grant T. Liu, MD. Professor of Neurology, University of Pennsylvania | |
| 24 |
 | Concise summaries. | | |
| 25 |
 | Information summaries. | | |
